Ribonuclease R (20 U/μL): Advancing Circular RNA Biology
2026-05-29
Explore how Ribonuclease R (20 U/μL) enables next-generation circular RNA enrichment and structure-function analysis. This in-depth article reveals advanced assay design and translational insights beyond current protocols.
Spiroplasma eriocheiris Entry via Clathrin-Mediated Endocyto
2026-05-28
This study demonstrates that Spiroplasma eriocheiris invades Drosophila Schneider 2 (S2) cells primarily through clathrin-mediated endocytosis and macropinocytosis, with entry effectively blocked by inhibitors such as Dynasore. The findings provide a detailed mechanistic framework for understanding host-pathogen interactions in invertebrates and establish S2 cells as a robust model for endocytosis research.
Overcoming Resistance in IDH1-Mutant AML: Mechanistic Strate
2026-05-28
This thought-leadership article explores the evolving landscape of mutant IDH1 inhibition in acute myeloid leukemia (AML), focusing on AG-120 (Ivosidenib) as a paradigm-shifting tool. It integrates mechanistic insights from recent research on CD44-mediated metabolic rewiring and addresses resistance mechanisms, offering translational researchers actionable guidance for designing combinatorial strategies. The discussion bridges molecular rationale, experimental design, and future outlook, pushing beyond standard product narratives and connecting current advances to clinical ambitions.
Necrosulfonamide (SKU B7731): Precision Tools for Necroptosi
2026-05-27
This article explores real-world laboratory challenges in necroptosis assay design and demonstrates how Necrosulfonamide (SKU B7731) from APExBIO provides reliable, specific, and reproducible inhibition of MLKL-driven cell death. Each scenario-driven Q&A is grounded in the latest literature and practical workflow recommendations, highlighting SKU B7731’s unique suitability for advanced cell death pathway research.
Cyclo (-RGDfC): Redefining Precision in Tumor Targeting Rese
2026-05-27
Explore how Cyclo (-RGDfC), a cyclic RGD peptide, is unlocking a new era of integrin αvβ3-targeted cancer research. This article blends mechanistic insight, high-throughput methodology, and strategic protocol guidance for translational scientists, leveraging emerging hydrogel and light-based activation platforms. APExBIO's product advances the field by offering specificity, stability, and workflow integration beyond conventional RGD peptides.
Metronidazole in Research: OAT3 Inhibition & Protocol Optimi
2026-05-26
Metronidazole (2-(2-methyl-5-nitroimidazol-1-yl)ethanol) stands apart as both an antibiotic and a research tool for dissecting OAT3-mediated drug interactions and microbiome-immune cross-talk. This article translates the latest evidence into actionable workflows and troubleshooting strategies for bench scientists.
Transmission of Carbapenemase Genes in CREC During COVID-19
2026-05-26
Chen et al. provide the first comprehensive characterization of carbapenemase-encoding genes (CEGs) and their transmission dynamics in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong during the COVID-19 pandemic. The study reveals high prevalence, multidrug resistance, and efficient horizontal gene transfer of CEGs, highlighting urgent challenges for antimicrobial stewardship and infection control.
Halazone and Oxidant Effects on Frog Nerve Sodium Channel In
2026-05-25
This article examines how Halazone and related oxidants modulate sodium current inactivation in myelinated frog nerve fibers, based on a seminal voltage-clamp study. The findings challenge prior assumptions about amino acid targeting and highlight the experimental value of membrane lipid modification pathways for neurophysiological research.
Salmonella Haem Biosynthesis Inhibits Macrophage Phagocytosi
2026-05-25
The reference study uncovers a post-translational mechanism by which Salmonella Typhimurium enhances haem biosynthesis to evade macrophage phagocytosis, promoting infection in mice. These findings clarify the role of pathogen-derived haem in immune evasion and have implications for the study of bacterial virulence and host-pathogen interactions.
PDHA1 Succinylation Drives Immune Evasion in Cholangiocarcin
2026-05-24
This study reveals that succinylation of PDHA1 at lysine 83 in cholangiocarcinoma cells leads to alpha-ketoglutaric acid accumulation, suppressing macrophage antigen presentation and facilitating immune escape. The findings highlight a novel metabolic-immune axis and suggest that targeting PDHA1 succinylation may enhance the efficacy of chemotherapeutics such as gemcitabine and cisplatin.
Halazone: Mechanistic Insights for Water Disinfection & Ion
2026-05-23
Explore Halazone as an advanced antimicrobial sulfonamide derivative, with unique mechanistic insights into its role as a water disinfection agent and a sodium channel modulator. This article delivers a rigorous, protocol-driven perspective for researchers seeking robust and reproducible applications.
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1
2026-05-22
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent optimized for efficient amide bond formation in in vitro peptide synthesis, bioconjugation, and nucleotide coupling workflows. It addresses the challenge of performing high-yield coupling reactions in aqueous media, but is not suitable for in vivo or clinical applications due to absent supporting data.
Amphotericin B: Molecular Insights and Immunomodulatory Role
2026-05-22
Explore the advanced biology of Amphotericin B, a polyene antifungal antibiotic, with a focus on its unique immunomodulatory effects and experimental design considerations. This article provides a distinct, scientifically rigorous perspective for fungal infection research.
Comparative Antibacterial Activity of N-Formimidoyl Thienamy
2026-05-21
This article examines the landmark comparative study evaluating N-formimidoyl thienamycin (MK0787) alongside ampicillin sodium and other β-lactam antibiotics against resistant clinical isolates. The findings provide insight into mechanisms of antibacterial efficacy and the nuanced roles of β-lactam agents in addressing contemporary resistance challenges.
Novel Indazole/Indole Glucagon Receptor Antagonists for T2DM
2026-05-21
The reference study introduces a new series of indazole- and indole-based glucagon receptor antagonists, designed with insights from the pyrazole-based lead MK 0893. These compounds demonstrate potent in vitro and in vivo efficacy in glucose lowering, offering valuable chemical scaffolds for type 2 diabetes research and expanding options for targeting dysregulated hepatic glucose production.
458 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page